Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 277

1.

QALY weights for diabetic retinopathy--a comparison of health state valuations with HUI-3, EQ-5D, EQ-VAS, and TTO.

Heintz E, Wiréhn AB, Peebo BB, Rosenqvist U, Levin LÅ.

Value Health. 2012 May;15(3):475-84. doi: 10.1016/j.jval.2011.11.031. Epub 2012 Feb 10.

2.

Assessment of health state in patients with tinnitus: a comparison of the EQ-5D and HUI mark III.

Maes IH, Joore MA, Cima RF, Vlaeyen JW, Anteunis LJ.

Ear Hear. 2011 Jul-Aug;32(4):428-35. doi: 10.1097/AUD.0b013e3181fdf09f.

PMID:
21221004
3.

Assessing utility values in rheumatoid arthritis: a comparison between time trade-off and the EuroQol.

Ariza-Ariza R, Hernández-Cruz B, Carmona L, Dolores Ruiz-Montesinos M, Ballina J, Navarro-Sarabia F; Costs and Quality of Life in Rheumatoid Arthritis Study Group.

Arthritis Rheum. 2006 Oct 15;55(5):751-6.

4.

Mapping the 25-item National Eye Institute Visual Functioning Questionnaire (NEI VFQ-25) to EQ-5D utility scores.

Kay S, Ferreira A.

Ophthalmic Epidemiol. 2014 Apr;21(2):66-78. doi: 10.3109/09286586.2014.888456. Epub 2014 Feb 25.

PMID:
24568628
5.

The EQ-5D and the Health Utilities Index for permanent sequelae after meningitis: a head-to-head comparison.

Oostenbrink R, A Moll HA, Essink-Bot ML.

J Clin Epidemiol. 2002 Aug;55(8):791-9.

PMID:
12384194
6.

Comparison of different valuation methods for population health status measured by the EQ-5D in three European countries.

Bernert S, Fernández A, Haro JM, König HH, Alonso J, Vilagut G, Sevilla-Dedieu C, de Graaf R, Matschinger H, Heider D, Angermeyer MC; ESEMeD/MHEDEA 2000 Investigators.

Value Health. 2009 Jul-Aug;12(5):750-8. doi: 10.1111/j.1524-4733.2009.00509.x.

7.

Estimating an EQ-5D value set for Malaysia using time trade-off and visual analogue scale methods.

Yusof FA, Goh A, Azmi S.

Value Health. 2012 Jan-Feb;15(1 Suppl):S85-90. doi: 10.1016/j.jval.2011.11.024.

8.

Validating the EQ-5D with time trade off for the German population.

Greiner W, Claes C, Busschbach JJ, von der Schulenburg JM.

Eur J Health Econ. 2005 Jun;6(2):124-30.

PMID:
19787848
9.

Health utility values associated with diabetic retinopathy.

Lloyd A, Nafees B, Gavriel S, Rousculp MD, Boye KS, Ahmad A.

Diabet Med. 2008 May;25(5):618-24. doi: 10.1111/j.1464-5491.2008.02430.x. Epub 2008 Mar 13. Review.

PMID:
18346157
10.

Measuring health-related quality of life in rheumatoid arthritis: validity, responsiveness and reliability of EuroQol (EQ-5D).

Hurst NP, Kind P, Ruta D, Hunter M, Stubbings A.

Br J Rheumatol. 1997 May;36(5):551-9.

PMID:
9189057
11.

Inconsistencies in TTO and VAS values for EQ-5D health states.

Lamers LM, Stalmeier PF, Krabbe PF, Busschbach JJ.

Med Decis Making. 2006 Mar-Apr;26(2):173-81.

PMID:
16525171
12.

Validity of EuroQOL-5D, time trade-off, and standard gamble for age-related macular degeneration in the Singapore population.

Au Eong KG, Chan EW, Luo N, Wong SH, Tan NW, Lim TH, Wagle AM.

Eye (Lond). 2012 Mar;26(3):379-88. doi: 10.1038/eye.2011.218. Epub 2012 Jan 6.

13.

The impact of diabetic retinopathy and diabetic macular edema on health-related quality of life in type 1 and type 2 diabetes.

Fenwick EK, Xie J, Ratcliffe J, Pesudovs K, Finger RP, Wong TY, Lamoureux EL.

Invest Ophthalmol Vis Sci. 2012 Feb 13;53(2):677-84. doi: 10.1167/iovs.11-8992.

PMID:
22205611
14.

Comparison of Health State Utility Measures in Patients With Head and Neck Cancer.

Noel CW, Lee DJ, Kong Q, Xu W, Simpson C, Brown D, Gilbert RW, Gullane PJ, Irish JC, Huang SH, O'Sullivan B, Goldstein DP, de Almeida JR.

JAMA Otolaryngol Head Neck Surg. 2015 Aug;141(8):696-703. doi: 10.1001/jamaoto.2015.1314.

PMID:
26204439
15.

TTO utility scores measure quality of life in patients with visual morbidity due to diabetic retinopathy or ARMD.

Shah VA, Gupta SK, Shah KV, Vinjamaram S, Chalam KV.

Ophthalmic Epidemiol. 2004 Feb;11(1):43-51.

PMID:
14977496
16.

A comparison of techniques for eliciting patient preferences in patients with benign prostatic hyperplasia.

Schulz MW, Chen J, Woo HH, Keech M, Watson ME, Davey PJ.

J Urol. 2002 Jul;168(1):155-9.

PMID:
12050512
17.

A comparison of individual and social time trade-off values for health states in the general population.

Burström K, Johannesson M, Diderichsen F.

Health Policy. 2006 May;76(3):359-70. Epub 2005 Oct 7.

PMID:
16214258
18.

Cost-utility analysis of cochlear implants in Korea using different measures of utility.

Lee HY, Park EC, Kim HJ, Choi JY, Kim HN.

Acta Otolaryngol. 2006 Aug;126(8):817-23.

PMID:
16846923
19.

Preference-based quality of life of patients on renal replacement therapy: a systematic review and meta-analysis.

Liem YS, Bosch JL, Hunink MG.

Value Health. 2008 Jul-Aug;11(4):733-41. doi: 10.1111/j.1524-4733.2007.00308.x. Epub 2008 Jan 8. Review.

20.

Patient and public preferences for health states associated with AMD.

Butt T, Dunbar HM, Morris S, Orr S, Rubin GS.

Optom Vis Sci. 2013 Aug;90(8):855-60. doi: 10.1097/OPX.0b013e3182962318.

PMID:
23811607

Supplemental Content

Support Center